The Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
NCT Number: NCT03514498
As anesthesia is often needed for childhood surgery and procedures, researchers have examined the potential effects of anesthesia on neurodevelopment. There are few studies that have examined the effect of anesthesia on neurodevelopment in children with confirmed diagnoses of ASD, and the results of these studies are mixed. Children with neurodevelopmental disorders can have age-dependent variations in brain anatomy, function, and connectivity, which may alter their sensitivity to the potential neurotoxic effects of anesthetic and sedative drugs. Given the potential adverse neurodevelopmental effects of anesthesia on typically developing children, it is important to examine if anesthesia exposure can worsen the clinical course of ASD.
Looking for future studies?
Notify Me4 year–12 year
All sexes
Observational
Toronto, Ontario, M5G 1X8, Canada
We hypothesize that children with a confirmed diagnosis of ASD will regress developmentally following general anesthesia for dental surgery in comparison to children without ASD (controls) undergoing dental surgery. In this pilot study, we will investigate this hypothesis through the following objectives:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For Autism Spectrum Disorder Group:
Exclusion criteria
for Autism Spectrum Disorder Group:
Inclusion criteria
for Typically Developed Controls Group:
All types of dental surgery
Time frame: up to 3 months before surgery
measured using the Autism Diagnostic Interview - Revised
Time frame: up to 12 weeks following anesthetic exposure
measured using the Autism Diagnostic Interview - Revised
Time frame: immediately prior to anesthetic exposure
measured using quantitative polymerase chain reactions
Time frame: within 1-2 hours following anesthetic exposure
measured using quantitative polymerase chain reactions
Time frame: up to 3 months before surgery
measured using the Abberant Behaviour Checklist
Time frame: up to 12 weeks following anesthetic exposure
measured using the Abberant Behaviour Checklist
Time frame: up to 3 months before surgery
measured using the Children's Sleep Habits Questionnaire
Time frame: up to 12 weeks following anesthetic exposure
measured using the Children's Sleep Habits Questionnaire
Time frame: up to 3 months before surgery
measured using the Social Communication Questionnaire
Time frame: up to 12 weeks following anesthetic exposure
measured using the Social Communication Questionnaire
Time frame: up to 3 months before surgery
measured using the Social Responsiveness Scale
Time frame: up to 12 weeks following anesthetic exposure
measured using the Social Responsiveness Scale
Time frame: 3 days following anesthetic exposure
measured using the Posthospitalization Behaviour Questionnaire
Time frame: up to 12 weeks following anesthetic exposure
measured using semi-structured interview
The Hospital for Sick Children
Other
Cognitive, Behavioural and Metabolic Effects of Anesthesia in Patients With Autism Spectrum Disorder: a Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06352372
Autism Spectrum Disorder, Autistic Disorder
Phoenix, Arizona, United States
View Trial DetailsNCT07277101
Autism Spectrum Disorder, Autistic Disorder
Shanghai, China
View Trial DetailsNCT06361147
Autism Spectrum Disorder, Child Development Disorders, Pervasive
Heraklion, Crete, Greece
View Trial DetailsNCT06508515
Autism Spectrum Disorder, Child Development Disorders, Pervasive
Seattle, Washington, United States
View Trial Details